LIDOCAINE HCI AND DEXTROSE

Product NDC: 51662-1565
11-digit product format: 516621565
Labeler code: 51662
Product ID: 51662-1565_c75311e3-ca6f-40de-e053-2a95a90a1bda
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: LIDOCAINE HCI AND DEXTROSE
Dosage form: INJECTION, SOLUTION
Route: INTRAVENOUS
Labeler: HF Acquisition Co LLC, DBA HealthFirst
Application: NDA019830
Marketing category: NDA
Marketing start: 2021-07-17
Marketing end: 0000-00-00
Substance: DEXTROSE MONOHYDRATE; LIDOCAINE HYDROCHLORIDE ANHYDROUS
Active strength: 5 g/100mL; g/100mL
Pharmacologic classes: Amide Local Anesthetic [EPC],Amides [CS],Antiarrhythmic [EPC],Local Anesthesia [PE]
NDC exclude flag: No
Listing certified through: 2022-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	51662-1565		D	Discontinued by firm		2026-10-20
excluded package	package	51662-1565	51662-1565-1	D	Discontinued by firm		2026-10-20

Source provenance: Browse the complete Orange Book source catalog · source snapshot 44.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	Approval date
N019830-002	LIDOCAINE HYDROCHLORIDE 0.2% AND DEXTROSE 5% IN PLASTIC CONTAINER	LIDOCAINE HYDROCHLORIDE	200MG/100ML	INJECTABLE / INJECTION	AP	1992-04-08
N019830-003	LIDOCAINE HYDROCHLORIDE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER	LIDOCAINE HYDROCHLORIDE	400MG/100ML	INJECTABLE / INJECTION	AP	1992-04-08
N019830-004	LIDOCAINE HYDROCHLORIDE 0.8% AND DEXTROSE 5% IN PLASTIC CONTAINER	LIDOCAINE HYDROCHLORIDE	800MG/100ML	INJECTABLE / INJECTION	AP	1992-04-08

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 3 matching rows.

Application-product, TE code table
Application-product	TE code
N019830-002	AP
N019830-003	AP
N019830-004	AP

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 4 · 132 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-10-15 13:18:30	2026-09	N019830-002	LIDOCAINE HYDROCHLORIDE 0.2% AND DEXTROSE 5% IN PLASTIC CONTAINER	200MG/100ML	INJECTABLE / INJECTION	AP	1992-04-08	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N019830-003	LIDOCAINE HYDROCHLORIDE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER	400MG/100ML	INJECTABLE / INJECTION	AP	1992-04-08	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N019830-004	LIDOCAINE HYDROCHLORIDE 0.8% AND DEXTROSE 5% IN PLASTIC CONTAINER	800MG/100ML	INJECTABLE / INJECTION	AP	1992-04-08	`c2088c7a36db…`
2026-09-14 22:38:34	2026-08	N019830-002	LIDOCAINE HYDROCHLORIDE 0.2% AND DEXTROSE 5% IN PLASTIC CONTAINER	200MG/100ML	INJECTABLE / INJECTION	AP	1992-04-08	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N019830-003	LIDOCAINE HYDROCHLORIDE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER	400MG/100ML	INJECTABLE / INJECTION	AP	1992-04-08	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N019830-004	LIDOCAINE HYDROCHLORIDE 0.8% AND DEXTROSE 5% IN PLASTIC CONTAINER	800MG/100ML	INJECTABLE / INJECTION	AP	1992-04-08	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N019830-002	LIDOCAINE HYDROCHLORIDE 0.2% AND DEXTROSE 5% IN PLASTIC CONTAINER	200MG/100ML	INJECTABLE / INJECTION	AP	1992-04-08	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N019830-003	LIDOCAINE HYDROCHLORIDE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER	400MG/100ML	INJECTABLE / INJECTION	AP	1992-04-08	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N019830-004	LIDOCAINE HYDROCHLORIDE 0.8% AND DEXTROSE 5% IN PLASTIC CONTAINER	800MG/100ML	INJECTABLE / INJECTION	AP	1992-04-08	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N019830-002	LIDOCAINE HYDROCHLORIDE 0.2% AND DEXTROSE 5% IN PLASTIC CONTAINER	200MG/100ML	INJECTABLE / INJECTION	AP	1992-04-08	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N019830-003	LIDOCAINE HYDROCHLORIDE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER	400MG/100ML	INJECTABLE / INJECTION	AP	1992-04-08	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N019830-004	LIDOCAINE HYDROCHLORIDE 0.8% AND DEXTROSE 5% IN PLASTIC CONTAINER	800MG/100ML	INJECTABLE / INJECTION	AP	1992-04-08	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N019830-002	LIDOCAINE HYDROCHLORIDE 0.2% AND DEXTROSE 5% IN PLASTIC CONTAINER	200MG/100ML	INJECTABLE / INJECTION	AP	1992-04-08	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N019830-003	LIDOCAINE HYDROCHLORIDE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER	400MG/100ML	INJECTABLE / INJECTION	AP	1992-04-08	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N019830-004	LIDOCAINE HYDROCHLORIDE 0.8% AND DEXTROSE 5% IN PLASTIC CONTAINER	800MG/100ML	INJECTABLE / INJECTION	AP	1992-04-08	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N019830-002	LIDOCAINE HYDROCHLORIDE 0.2% AND DEXTROSE 5% IN PLASTIC CONTAINER	200MG/100ML	INJECTABLE / INJECTION	AP	1992-04-08	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N019830-003	LIDOCAINE HYDROCHLORIDE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER	400MG/100ML	INJECTABLE / INJECTION	AP	1992-04-08	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N019830-004	LIDOCAINE HYDROCHLORIDE 0.8% AND DEXTROSE 5% IN PLASTIC CONTAINER	800MG/100ML	INJECTABLE / INJECTION	AP	1992-04-08	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N019830-002	LIDOCAINE HYDROCHLORIDE 0.2% AND DEXTROSE 5% IN PLASTIC CONTAINER	200MG/100ML	INJECTABLE / INJECTION	AP	1992-04-08	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N019830-003	LIDOCAINE HYDROCHLORIDE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER	400MG/100ML	INJECTABLE / INJECTION	AP	1992-04-08	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N019830-004	LIDOCAINE HYDROCHLORIDE 0.8% AND DEXTROSE 5% IN PLASTIC CONTAINER	800MG/100ML	INJECTABLE / INJECTION	AP	1992-04-08	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N019830-002	LIDOCAINE HYDROCHLORIDE 0.2% AND DEXTROSE 5% IN PLASTIC CONTAINER	200MG/100ML	INJECTABLE / INJECTION	AP	1992-04-08	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N019830-003	LIDOCAINE HYDROCHLORIDE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER	400MG/100ML	INJECTABLE / INJECTION	AP	1992-04-08	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N019830-004	LIDOCAINE HYDROCHLORIDE 0.8% AND DEXTROSE 5% IN PLASTIC CONTAINER	800MG/100ML	INJECTABLE / INJECTION	AP	1992-04-08	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N019830-002	LIDOCAINE HYDROCHLORIDE 0.2% AND DEXTROSE 5% IN PLASTIC CONTAINER	200MG/100ML	INJECTABLE / INJECTION	AP	1992-04-08	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N019830-003	LIDOCAINE HYDROCHLORIDE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER	400MG/100ML	INJECTABLE / INJECTION	AP	1992-04-08	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N019830-004	LIDOCAINE HYDROCHLORIDE 0.8% AND DEXTROSE 5% IN PLASTIC CONTAINER	800MG/100ML	INJECTABLE / INJECTION	AP	1992-04-08	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N019830-002	LIDOCAINE HYDROCHLORIDE 0.2% AND DEXTROSE 5% IN PLASTIC CONTAINER	200MG/100ML	INJECTABLE / INJECTION	AP	1992-04-08	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N019830-003	LIDOCAINE HYDROCHLORIDE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER	400MG/100ML	INJECTABLE / INJECTION	AP	1992-04-08	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N019830-004	LIDOCAINE HYDROCHLORIDE 0.8% AND DEXTROSE 5% IN PLASTIC CONTAINER	800MG/100ML	INJECTABLE / INJECTION	AP	1992-04-08	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N019830-002	LIDOCAINE HYDROCHLORIDE 0.2% AND DEXTROSE 5% IN PLASTIC CONTAINER	200MG/100ML	INJECTABLE / INJECTION	AP	1992-04-08	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N019830-003	LIDOCAINE HYDROCHLORIDE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER	400MG/100ML	INJECTABLE / INJECTION	AP	1992-04-08	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N019830-004	LIDOCAINE HYDROCHLORIDE 0.8% AND DEXTROSE 5% IN PLASTIC CONTAINER	800MG/100ML	INJECTABLE / INJECTION	AP	1992-04-08	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N019830-002	LIDOCAINE HYDROCHLORIDE 0.2% AND DEXTROSE 5% IN PLASTIC CONTAINER	200MG/100ML	INJECTABLE / INJECTION	AP	1992-04-08	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N019830-003	LIDOCAINE HYDROCHLORIDE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER	400MG/100ML	INJECTABLE / INJECTION	AP	1992-04-08	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N019830-004	LIDOCAINE HYDROCHLORIDE 0.8% AND DEXTROSE 5% IN PLASTIC CONTAINER	800MG/100ML	INJECTABLE / INJECTION	AP	1992-04-08	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N019830-002	LIDOCAINE HYDROCHLORIDE 0.2% AND DEXTROSE 5% IN PLASTIC CONTAINER	200MG/100ML	INJECTABLE / INJECTION	AP	1992-04-08	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N019830-003	LIDOCAINE HYDROCHLORIDE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER	400MG/100ML	INJECTABLE / INJECTION	AP	1992-04-08	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N019830-004	LIDOCAINE HYDROCHLORIDE 0.8% AND DEXTROSE 5% IN PLASTIC CONTAINER	800MG/100ML	INJECTABLE / INJECTION	AP	1992-04-08	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N019830-002	LIDOCAINE HYDROCHLORIDE 0.2% AND DEXTROSE 5% IN PLASTIC CONTAINER	200MG/100ML	INJECTABLE / INJECTION	AP	1992-04-08	`79d66fd596c7…`

Observed Orange Book normalized TE history#

Normalized TE history page 2 of 4 · 132 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N019830-003	AP	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N019830-004	AP	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N019830-002	AP	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N019830-003	AP	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N019830-004	AP	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N019830-002	AP	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N019830-003	AP	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N019830-004	AP	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N019830-002	AP	1	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	N019830-003	AP	1	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	N019830-004	AP	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N019830-002	AP	1	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N019830-003	AP	1	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N019830-004	AP	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N019830-002	AP	1	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	N019830-003	AP	1	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	N019830-004	AP	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N019830-002	AP	1	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	N019830-003	AP	1	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	N019830-004	AP	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N019830-002	AP	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N019830-003	AP	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N019830-004	AP	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N019830-002	AP	1	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	N019830-003	AP	1	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	N019830-004	AP	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N019830-002	AP	1	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	N019830-003	AP	1	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	N019830-004	AP	1	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N019830-002	AP	1	`87673890dc5c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N019830-003	AP	1	`87673890dc5c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N019830-004	AP	1	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N019830-002	AP	1	`5aa47cf7b7d7…`
2021-03-12 10:30 UTC	2021-03	N019830-003	AP	1	`5aa47cf7b7d7…`
2021-03-12 10:30 UTC	2021-03	N019830-004	AP	1	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N019830-002	AP	1	`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	N019830-003	AP	1	`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	N019830-004	AP	1	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N019830-002	AP	1	`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	N019830-003	AP	1	`c0c555d07b60…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
860a93dc-4863-49cc-b284-6bbe8191bc48	Product name	4	20250214
eaba870a-6a9d-442e-8643-87b3f558a451	Product name	1	20250117
cb89b86a-369e-4204-8910-ae797c503af3	Product name	1	20230706
9b4cf230-fd05-41d5-98c6-5db9ecb27b86	Product name	1	20230117
d4880ace-a516-8c47-8dfd-73a4ba5887d7	Product name	2	20180830
7cda52fc-125f-421c-8fea-bc1974370c49	Product name	2	20180703
fa8b5901-e681-426f-82fe-54f6d81ec698	Product name	4	20180619
332d03e4-aa24-4b11-841a-02bf41081920	Product name	1	20171221
c08ab52f-2fc8-4409-9d9f-ed8edc0bd070	Product name	1	20171221
0ca1d589-929b-4b33-bc5b-1d84abdafa6a	Product name	1	20150324
fc363c46-397b-4476-ac0f-70e43e8e4592	Product name	1	20150324
68ed98f8-24c2-44a0-944a-6d36e82ce25a	Product name	1	20141222
1cd42bc2-a430-c72b-636d-991b235fbf80	Product name	1	20140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
51662-1565-1	LIDOCAINE HCI AND DEXTROSE	250 mL in 1 CONTAINER	INJECTION, SOLUTION	250		1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
51662-1565	LIDOCAINE HCI AND DEXTROSE INJECTION, SOLUTION [HF ACQUISITION CO LLC, DBA HEALTHFIRST]	1	Legacy NDC, 1 package rows	20210719_c75311e3-ca6e-40de-e053-2a95a90a1bda.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Lidocaine Hydrochloride and Dextrose	LIDOCAINE HYDROCHLORIDE ANHYDROUS AND DEXTROSE MONOHYDRATE	ProPharma Distribution	48c0ee87-f722-1a71-e063-6394a90a72d1	2026-01-19	Warnings, Adverse reactions	Exact identifier application applno (NDA): 019830 application number: NDA019830
Lidocaine Hydrochloride and Dextrose	LIDOCAINE HYDROCHLORIDE ANHYDROUS AND DEXTROSE MONOHYDRATE	B. Braun Medical Inc.	7dff29d9-522d-40eb-a9d9-42377912d640	2026-01-14	Warnings, Adverse reactions	Exact identifier application applno (NDA): 019830 application number: NDA019830

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
LX22YL083G	DEXTROSE MONOHYDRATE	77938-63-7	DEXTROSE MONOHYDRATE
EC2CNF7XFP	LIDOCAINE HYDROCHLORIDE ANHYDROUS	73-78-9	LIDOCAINE HYDROCHLORIDE ANHYDROUS

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
1737723	lidocaine HCl 0.8 % in 250 ML Injection	PSN	c75311e3-ca6e-40de-e053-2a95a90a1bda	1
1737723	250 ML lidocaine hydrochloride 8 MG/ML Injection	SCD	c75311e3-ca6e-40de-e053-2a95a90a1bda	1
1737723	lidocaine HCl 0.8 % per 250 ML Injection	SY	c75311e3-ca6e-40de-e053-2a95a90a1bda	1
1737723	lidocaine HCl 2 GM per 250 ML Injection	SY	c75311e3-ca6e-40de-e053-2a95a90a1bda	1

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
51662-1565-1	51662156501	250 mL in 1 CONTAINER (51662-1565-1)	250 ml	2021-07-17	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
LIDOCAINE HCI AND 5% DEXTROSE INJECTION USP, 2g (8mg/mL)	HF Acquisition Co LLC, DBA HealthFirst	2021-07-17	HUMAN PRESCRIPTION DRUG LABEL	1